An overview of safety and regulatory aspects of the new biotechnology.

New technology is producing new drugs and biologic products that present novel safety issues for the regulatory agencies. These products are produced using recombinant DNA or hybridoma techniques. Examples are growth hormone, antihemophilic factor, and interferon, produced by recombinant DNA. Very special proteins, namely, monoclonal antibodies, can be made… (More)